Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Quinn William P. | Dec 12, 2023 | Buy | 7,500 | $0.95 | $7,100 |
| Yonehiro Grant | Dec 6, 2023 | Buy | 2,500 | $0.782 | $2,000 |
| Perez Edith A. | Dec 6, 2023 | Buy | 2,500 | $0.782 | $2,000 |
| Schatzman Randall C | Dec 6, 2023 | Buy | 2,500 | $0.782 | $2,000 |
| Quinn William P. | Dec 6, 2023 | Buy | 2,500 | $0.782 | $2,000 |
| ENGLEMAN EDGAR | Nov 30, 2023 | Sell | 108,145 | $0.8581 | $93,000 |
| ENGLEMAN EDGAR | Nov 30, 2023 | Sell | 14,934 | $0.8581 | $13,000 |
| ENGLEMAN EDGAR | Nov 29, 2023 | Sell | 22,674 | $0.906 | $21,000 |
| ENGLEMAN EDGAR | Nov 29, 2023 | Sell | 3,131 | $0.906 | $2,800 |
| Vivo Capital Fund VIII, L.P. | Nov 21, 2023 | Sell | 1,707 | $0.9 | $1,500 |
| Vivo Capital Fund VIII, L.P. | Nov 21, 2023 | Sell | 1,457 | $0.9 | $1,300 |
| ENGLEMAN EDGAR | Nov 21, 2023 | Sell | 1,707 | $0.9014 | $1,500 |
| Vivo Capital Fund VIII, L.P. | Nov 21, 2023 | Sell | 236 | $0.9 | $210 |
| ENGLEMAN EDGAR | Nov 21, 2023 | Sell | 236 | $0.9014 | $210 |
| Vivo Capital Fund VIII, L.P. | Nov 20, 2023 | Sell | 27,465 | $0.92 | $25,000 |
| Vivo Capital Fund VIII, L.P. | Nov 20, 2023 | Sell | 23,443 | $0.92 | $22,000 |
| ENGLEMAN EDGAR | Nov 20, 2023 | Sell | 27,465 | $0.92 | $25,000 |
| Vivo Capital Fund VIII, L.P. | Nov 20, 2023 | Sell | 3,792 | $0.92 | $3,500 |
| ENGLEMAN EDGAR | Nov 20, 2023 | Sell | 3,792 | $0.92 | $3,500 |
| Vivo Capital Fund VIII, L.P. | Nov 17, 2023 | Sell | 8,211 | $0.93 | $7,600 |
| Vivo Capital Fund VIII, L.P. | Nov 17, 2023 | Sell | 7,009 | $0.93 | $6,500 |
| Vivo Capital Fund VIII, L.P. | Nov 17, 2023 | Sell | 1,134 | $0.93 | $1,100 |
| ENGLEMAN EDGAR | Nov 17, 2023 | Sell | 8,211 | $0.93 | $7,600 |
| ENGLEMAN EDGAR | Nov 17, 2023 | Sell | 1,134 | $0.93 | $1,100 |
| Vivo Capital Fund VIII, L.P. | Nov 16, 2023 | Sell | 7,531 | $0.96 | $7,200 |
| Vivo Capital Fund VIII, L.P. | Nov 16, 2023 | Sell | 6,429 | $0.96 | $6,200 |
| Vivo Capital Fund VIII, L.P. | Nov 16, 2023 | Sell | 1,040 | $0.96 | $1,000 |
| ENGLEMAN EDGAR | Nov 16, 2023 | Sell | 7,531 | $0.96 | $7,200 |
| ENGLEMAN EDGAR | Nov 16, 2023 | Sell | 1,040 | $0.96 | $1,000 |
| Perez Edith A. | Jun 6, 2023 | Buy | 2,070 | $1.1815 | $2,400 |
| Quinn William P. | Jun 6, 2023 | Buy | 1,829 | $1.1815 | $2,200 |
What's the latest insider transaction for Bolt Biotherapeutics?
The most recent insider transaction for Bolt Biotherapeutics was conducted by Quinn William P., who sold 7,500 shares on December 12, 2023 at a price of $0.95 per share.
Which insider bought the most BOLT stock over the last two years?
Quinn William P. has bought the most BOLT stock in the last 2 years, with a total value of $11,000.
Which insider has sold the most BOLT stock over the last two years?
ENGLEMAN EDGAR has sold the most BOLT stock in the last 2 years, with a total value of $180,000.
What is the total value of insider transactions for Bolt Biotherapeutics (BOLT) in the last 2 years?
The total value of insider transactions for Bolt Biotherapeutics in the last 2 years is negative, amounting to -$240,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Bolt Biotherapeutics' market confidence?
Over the last 2 years, insider transactions for Bolt Biotherapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
